German Parliamentary Group on AMR

๐€๐ฌ ๐๐ซ๐ฎ๐  ๐ซ๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐œ๐ž ๐š๐œ๐œ๐ž๐ฅ๐ž๐ซ๐š๐ญ๐ž๐ฌ, ๐ญ๐ก๐ž ๐ง๐ž๐ž๐ ๐Ÿ๐จ๐ซ ๐ง๐ž๐ฐ ๐š๐ง๐ญ๐ข๐›๐ข๐จ๐ญ๐ข๐œ๐ฌ ๐ก๐š๐ฌ ๐ง๐ž๐ฏ๐ž๐ซ ๐›๐ž๐ž๐ง ๐ ๐ซ๐ž๐š๐ญ๐ž๐ซโ€”๐š๐ง๐ ๐†๐ž๐ซ๐ฆ๐š๐ง๐ฒ ๐ข๐ฌ ๐ฌ๐ก๐จ๐ฐ๐ข๐ง๐  ๐ญ๐ก๐ž ๐ฉ๐จ๐ฅ๐ข๐ญ๐ข๐œ๐š๐ฅ ๐ฐ๐ข๐ฅ๐ฅ ๐ญ๐จ ๐š๐œ๐ญ

On 24 September 2025, the ๐๐š๐ซ๐ฅ๐ข๐š๐ฆ๐ž๐ง๐ญ๐š๐ซ๐ฒ ๐†๐ซ๐จ๐ฎ๐ฉ ๐จ๐ง ๐€๐ง๐ญ๐ข๐ฆ๐ข๐œ๐ซ๐จ๐›๐ข๐š๐ฅ ๐‘๐ž๐ฌ๐ข๐ฌ๐ญ๐š๐ง๐œ๐ž reconvened in Berlin, bringing together parliamentarians and experts to address AMR and the market incentives needed to spur antibiotic innovation.

We were pleased to have Dr. Ralf Sudbrak represent the Hub at the event, contributing valuable insights to this important conversation.

We also congratulate Reps. Stephan Albani (CDU) and Dr. Franziska Kersten (SPD) on their election as chair and co-chair of the Group. Their leadership reflects Germanyโ€”and the governing Grand Coalitionโ€™sโ€”commitment to advancing solutions to AMR.

Designing incentives for antibiotic development requires courage and bold thinkingโ€”and Germanyโ€™s parliamentarians are stepping up to meet the challenge!

 


Curious about more?

You can sign up for our newsletter here. By subscribing, you automatically provide your consent for the use of your data in accordance with our privacy policy.

This field is for validation purposes and should be left unchanged.

Latest news

Go to all news
Dynamic Dashboard